# Gene Transfer Clinical Study in Crigler-Najjar Syndrome

> **NCT03223194** · PHASE1 · TERMINATED · sponsor: **Audentes Therapeutics** · enrollment: 1 (actual)

## Conditions studied

- Crigler-Najjar Syndrome

## Interventions

- **GENETIC:** AT342

## Key facts

- **NCT ID:** NCT03223194
- **Lead sponsor:** Audentes Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-08
- **Primary completion:** 2021-02-11
- **Final completion:** 2021-02-11
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Sponsor Decision
- **Last updated:** 2022-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03223194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03223194, "Gene Transfer Clinical Study in Crigler-Najjar Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03223194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*